share_log

山东新华制药股份(00719.HK):获得泼尼松化学原料药上市申请批准通知书

Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK): Obtained a notice of approval for the marketing application of prednisone chemical raw materials

Gelonghui Finance ·  Feb 28 03:44

Gelonghui, Feb. 28, 丨 Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) issued an announcement. Recently, the company received approval from the State Drug Administration to issue the “Notice of Approval of the Marketing Application for Chemical Ingredients” relating to the Company's prednisone (“Product”). This product has anti-inflammatory and anti-allergic effects, can inhibit connective tissue proliferation, reduce the permeability of capillary walls and cell membranes, reduce inflammatory exudation, and inhibit the formation and release of histamine and other toxic substances. In severe toxic infections, this product can be used in combination with a large number of antibacterial drugs to have good cooling, anti-toxic, anti-inflammatory, anti-shock and symptom relief effects.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment